These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24672981)

  • 21. The role of incretin hormones and glucagon in patients with liver disease.
    Junker AE
    Dan Med J; 2017 May; 64(5):. PubMed ID: 28552096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increasing fat content from 20 to 45 wt% in a complex diet induces lower endotoxemia in parallel with an increased number of intestinal goblet cells in mice.
    Benoit B; Laugerette F; Plaisancié P; Géloën A; Bodennec J; Estienne M; Pineau G; Bernalier-Donadille A; Vidal H; Michalski MC
    Nutr Res; 2015 Apr; 35(4):346-56. PubMed ID: 25687164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incretins.
    Wu T; Rayner CK; Horowitz M
    Handb Exp Pharmacol; 2016; 233():137-71. PubMed ID: 25903418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
    Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
    Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Incretin and incretin-based therapies].
    Harada N; Inagaki N
    Nihon Rinsho; 2010 May; 68(5):931-42. PubMed ID: 20446595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in type 1 and type 2 rat diabetic models.
    Villanueva-Peñacarrillo ML; Puente J; Redondo A; Clemente F; Valverde I
    Endocrine; 2001 Jul; 15(2):241-8. PubMed ID: 11720253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intestinal nutrient sensing and blood glucose control.
    Zietek T; Daniel H
    Curr Opin Clin Nutr Metab Care; 2015 Jul; 18(4):381-8. PubMed ID: 26001654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.
    Lewis GF; Carpentier A; Adeli K; Giacca A
    Endocr Rev; 2002 Apr; 23(2):201-29. PubMed ID: 11943743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids.
    Smith U; Kahn BB
    J Intern Med; 2016 Nov; 280(5):465-475. PubMed ID: 27699898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GLUT2 and the incretin receptors are involved in glucose-induced incretin secretion.
    Cani PD; Holst JJ; Drucker DJ; Delzenne NM; Thorens B; Burcelin R; Knauf C
    Mol Cell Endocrinol; 2007 Sep; 276(1-2):18-23. PubMed ID: 17681422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the pathophysiology of late onset non-insulin dependent diabetes mellitus. Current controversies and new insights.
    Vaag A
    Dan Med Bull; 1999 Jun; 46(3):197-234. PubMed ID: 10421979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut Peptides Are Novel Regulators of Intestinal Lipoprotein Secretion: Experimental and Pharmacological Manipulation of Lipoprotein Metabolism.
    Xiao C; Dash S; Morgantini C; Adeli K; Lewis GF
    Diabetes; 2015 Jul; 64(7):2310-8. PubMed ID: 26106188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbiota and diabetes: an evolving relationship.
    Tilg H; Moschen AR
    Gut; 2014 Sep; 63(9):1513-21. PubMed ID: 24833634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic endotoxemia initiates obesity and insulin resistance.
    Cani PD; Amar J; Iglesias MA; Poggi M; Knauf C; Bastelica D; Neyrinck AM; Fava F; Tuohy KM; Chabo C; Waget A; Delmée E; Cousin B; Sulpice T; Chamontin B; Ferrières J; Tanti JF; Gibson GR; Casteilla L; Delzenne NM; Alessi MC; Burcelin R
    Diabetes; 2007 Jul; 56(7):1761-72. PubMed ID: 17456850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of glucagon-like peptide-1-(7-36) amide secretion by intestinal neurotransmitters and hormones in the isolated vascularly perfused rat colon.
    Plaisancie P; Bernard C; Chayvialle JA; Cuber JC
    Endocrinology; 1994 Dec; 135(6):2398-403. PubMed ID: 7988423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential New Approaches to Modifying Intestinal GLP-1 Secretion in Patients with Type 2 Diabetes Mellitus : Focus on Bile Acid Sequestrants.
    Holst JJ; McGill MA
    Clin Drug Investig; 2012 Jan; 32(1):1-14. PubMed ID: 27933595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbiota dysbiosis caused by dietetic patterns as a promoter of Alzheimer's disease through metabolic syndrome mechanisms.
    Navalón-Monllor V; Soriano-Romaní L; Silva M; de Las Hazas ML; Hernando-Quintana N; Suárez Diéguez T; Esteve PM; Nieto JA
    Food Funct; 2023 Aug; 14(16):7317-7334. PubMed ID: 37470232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The incretin system and its role in type 2 diabetes mellitus.
    Holst JJ; Vilsbøll T; Deacon CF
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):127-36. PubMed ID: 18786605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.